Pharmacological actions of phosphocholine 2,6-xylyl ether bromide (phospho-TM10; PTM10).
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002794:Choline / Q000494:pharmacology*; D004987:Ethers / Q000494:pharmacology; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009469:Neuromuscular Junction / Q000187:drug effects; D009474:Neurons / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D063065:Organophosphonates / Q000494:pharmacology*; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*; D014992:Xylenes / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000779:Anesthetics, Local; D004987:Ethers; D005730:Ganglionic Blockers; D063065:Organophosphonates; D013565:Sympatholytics; D014992:Xylenes; D002794:Choline